Our latest thinking on biopharmaceutical development and commercialization.
August 12, 2016
The Art & Science of Evidence -- Rare Disease: An integrated, patient-centered approach to research and commercialization
Integrating disparate data will usher in a new era of patient-powered research.
Fresh ideas and insights from our experts around the globe